ArticleBlood advances2017

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.

John-Paul Westwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.